Nutraceutical companies are constantly exploring innovative dosage forms to administer supplements in an easy-to-consume format. One such dosage form that has been gaining popularity is mini tablets that allow paediatric and geriatric patients improved comfort in consuming their supplements. However, the economical production of mini tablets puts a strain on formulation development, especially due to process complexities. SuperTab® 40LL is a co-processed product that combines the critical functionalities of enhanced flow, superior compaction and high dispersibility into one single ingredient. Consequently, it expands the limits of direct compression, making it the ingredient of choice for mini-tablets and other challenging nutraceutical formulations.